SU655307A3 - Method of obtaining guanidine derivatives or salts thereof - Google Patents
Method of obtaining guanidine derivatives or salts thereofInfo
- Publication number
- SU655307A3 SU655307A3 SU762324510A SU2324510A SU655307A3 SU 655307 A3 SU655307 A3 SU 655307A3 SU 762324510 A SU762324510 A SU 762324510A SU 2324510 A SU2324510 A SU 2324510A SU 655307 A3 SU655307 A3 SU 655307A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- radical
- carbon atoms
- carbon
- atom
- general formula
- Prior art date
Links
- 150000002357 guanidines Chemical class 0.000 title claims description 3
- 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 title claims description 3
- 238000000034 method Methods 0.000 title description 5
- 150000003839 salts Chemical class 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 239000000571 coke Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 5
- 229910052799 carbon Inorganic materials 0.000 claims 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 239000002574 poison Substances 0.000 claims 1
- 231100000614 poison Toxicity 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 235000019439 ethyl acetate Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 2
- -1 for example Substances 0.000 description 2
- ZLOPIFKNSKCBBQ-UHFFFAOYSA-N 2-(2,2-diethoxyethyl)guanidine Chemical compound CCOC(OCC)CN=C(N)N ZLOPIFKNSKCBBQ-UHFFFAOYSA-N 0.000 description 1
- OXQGTIUCKGYOAA-UHFFFAOYSA-N 2-Ethylbutanoic acid Chemical compound CCC(CC)C(O)=O OXQGTIUCKGYOAA-UHFFFAOYSA-N 0.000 description 1
- LYIIBVSRGJSHAV-UHFFFAOYSA-N 2-aminoacetaldehyde Chemical compound NCC=O LYIIBVSRGJSHAV-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- XTEGVFVZDVNBPF-UHFFFAOYSA-L naphthalene-1,5-disulfonate(2-) Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1S([O-])(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-L 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Description
(54) СПОСОБ ПОЛУЧЕНИЯ ПРОИЗЕЮДНЫХ ГУАНИПИНОВ ИЛИ ИХ СОЛЕЙ 3 В питературе описано попучение производных гуаницина путем взаимодей стви соответствующих апкипизотиомоче вин при повышенных температуре и давл нии в пол рном растворителе, например в смеси воды и диметипформамида, в присутствии минеральной киспоты l, однако отсутствуют какие-либо сведени о способе получени производных гаунидина общей формулы I , обладающих ценными свойствами. Цепью предлагаемого способа 5тп ет расширение ассортимента фармакологически активных соединений, в частности производных гуанидина. В соответствии с изобретением соед нени формулы I получают посредством того, что соединение формулы-Ц S-R9 где К, Я, Rj 6 имеют указанное выше значение и означает а кильную группу числом атомов углерода , подвергают взаимодействию с соединением формулы 111 где К 2 а 13 5 имеют указанные выше зна чени , в присутствии минеральной кислоты , например хпористовОдородной, бромистоводородньй , иодисговодородной или серной киспоты, в инертном растворите- пе ал,й -расплаве. Предпочтитепьцо про цесс провод т в присутствии по крайней мере эквивалентного копичества мине рапьной киспоты, в расчете на соединени формулы , однако соединени фор мулы 5 или Щ могут также испопь зоватьс и в частично непротонированной форме. Соединени формулы I могут находитьс в форме свободных оснований или в форме аддитивных сопей кислот. Из свободных оснований могут быть известным путем получены аддитивные соли кислот, в частности ацетаты или гидромалеинаты . Целевые продукты выдел ют известными способами в виде свободных оснований или в виде солей. Пример .1. 1-(5-Хлориндопин- 1-ип)-2-цик лопропи лгуани цин. 074 . 1.2 г гнцрохпор аа .1.-(5-хлоринаопнн-1-иил ) -2-метипизотиомочевины раствор ют в 6о МП метанола и нагревают с 15 мл циклопропиламина до 1ОО С в автоклаве в течение 5 ч. Реакционный раствор упаривают досуха и экстрагируют остаток путем встр хивани между уксусным эфиром и разбавленным раствором гидроокиси натри . Сырой 1-{5-.jatopHHflonHH -1-ил)-2-циклопропилгуанидин, полученный при упаривании высушенного над сульфатом магни уксусноэфирного раствора, кристаллизуют из уксусного эфира; т. пп. 146-.149°С. П р и м е р 2. 1-Окси-2-(индолин-1-ил )гуанидин. ; 10 г гиарохлорида 1-{индолин-1-ил)-2-метилизотиомочевины и 11,4 г гидрохлорида гидроксиламина суспендируют в 240 мп этанола и после добавлени 6,9 г этилата кали нагревают до кипени в течение 1 ч. После охлаждени отсасьтвают хлорид кали и избыточное количество гидрохлорида гидроксиламина и упаривают фильтрат досуха. Остаток от вьтаривани экстрагируют путем встр хивани между концентрированным водным раствором аммиака и метиленхлоридом . Высушенный над сульфатом магни метиленхлоридный раствор упаривают досуха . Полученный в видеостатка от выпа- ривани 1-окси-2-(индопин-1-ип) -гуанидин кристаллизуют после добавлени уксусной киспоты в виде ацетата из смеси этанол - простой эфир; т.пл. 155-156 С. П р и м е р 3. 1л(5-Хлориндолин-1-ип )2-(2,2-диэтоксиэтил) -гуанидин. 6 г гйдрохлорида 1-(5-хлориндолин-1-ип )-2-метилизотиомочевины и 1О мл аминоацатальдегиддиэтиладетал нагревают в течение 1 ч до температуры бани 120 С, Избыточное количество аминоапетальдегиддиэтипацетал испар ют в вакууме и остаток экстрагируют путем встр хивани между уксусным ефиром и 1 «.раствором гидроокиси натри . Высушенный над супьфатом магни уксусноэфирный раствор упаривают досуха. Полученный в виде остатка от выпаривани 1-(5-хлориндопиН 1-ип )-2-(2,2-аиэтоксиэтил) -гуанидин кристаллизуют в виде нафталин -1,5-дисульфоната из смеси этанол-простой эфир т. пп, 163-165 С. Аналогичным способом, использу в качестве исходного продукта соответствующие соединени формулы | , в которой Нд означает метил, путем взаимоцействи с соответстБующими соединени ми формулы получают соединепч формулы I , привепенные в таблице .(54) METHOD FOR PRODUCING PROIZEYUDNYH GUANIPINOV OR THEIR SALTS 3 piterature described popuchenie derivatives guanitsina by interaction respective apkipizotiomoche wines at elevated temperature and Pressure Research Institute in a polar solvent such as a mixture of water and dimetipformamida, in the presence of a mineral kispoty l, but there are - information about the method of obtaining Gaunidine derivatives of general formula I, possessing valuable properties. The chain of the proposed method 5tp expansion of the range of pharmacologically active compounds, in particular, guanidine derivatives. In accordance with the invention, compounds of the formula I are obtained by the fact that a compound of the formula -C S-R9 where K, I, Rj 6 have the above value and means a carbonyl group by the number of carbon atoms, is reacted with a compound of the formula 111 where 13 5 are as defined above, in the presence of a mineral acid, for example, hydrogen chloride, hydrobromic acid, hydrogen sulfide, or sulfuric acid, in an inert solvent, and melt. The preferred process is carried out in the presence of at least an equivalent amount of a mineral acid, based on the compounds of the formula, however, the compounds of Formula 5 or Y can also be used in a partially non-protonated form. The compounds of formula I may be in the form of free bases or in the form of additive acid cokes. Additive salts of acids, in particular acetates or hydromaleates, can be obtained from free bases in a known manner. The desired products are isolated by known methods in the form of free bases or in the form of salts. Example .1. 1- (5-Chlorindopin-1-ip) -2-cycle lopropi lguani tsin. 074. 1.2 g of cholesterol aa .1 .- (5-chlorinopen-1-yl) -2-methypisothiourea are dissolved in 6 MP of methanol and heated with 15 ml of cyclopropylamine to 1OO C in an autoclave for 5 hours. The reaction solution is evaporated to dryness and extracted with a residue by shaking between ethyl acetate and dilute sodium hydroxide solution. The crude 1- {5-.jatopHHflonHH -1-yl) -2-cyclopropylguanidine, obtained by evaporation of the magnesium sulphate acetic ester solution, is crystallized from ethyl acetate; m.p. 146-.149 ° C. PRI mme R 2. 1-Oxy-2- (indolin-1-yl) guanidine. ; 10 g of 1- {indolin-1-yl) -2-methylisothiourea urea hydrochloride and 11.4 g of hydroxylamine hydrochloride are suspended in 240 mp of ethanol and heated to boiling for 1 hour after the addition of 6.9 g of potassium ethoxide. After cooling, potassium chloride is evaporated and excess hydroxylamine hydrochloride and evaporate the filtrate to dryness. The residue from extraction was extracted by shaking between concentrated aqueous ammonia and methylene chloride. The methylene chloride solution, dried over magnesium sulfate, is evaporated to dryness. The 1-hydroxy-2- (indopin-1-ip) -guanidine obtained in the video residue from evaporation is crystallized after adding acetic acid in the form of acetate from ethanol-ether mixture; m.p. 155-156 C. PRI me R 3. 1l (5-Chlorindolin-1-ip) 2- (2,2-diethoxyethyl) -guanidine. 6 g of hydrochloride 1- (5-chloroindolin-1-ip) -2-methylisothiourea and 1 O ml of aminoacetaldehyde diethyldetal are heated for 1 hour to a bath temperature of 120 ° C. Excess amount of aminoapetaldehyde diethylacetate is evaporated in a vacuum, and the residue is extracted by means of distillation and in a range of 300 h. 1 ". Sodium hydroxide solution. The acetic ether solution, dried over magnesium sulfate, is evaporated to dryness. Obtained as a residue from evaporation of 1- (5-hlorindopiN 1-ip) -2- (2,2-aiethoxyethyl) -guanidine is crystallized as naphthalene -1,5-disulfonate from ethanol-ether mixture, m.p., 163- 165 C. In a similar way, using the corresponding compounds of the formula | in which Nd is methyl, by reacting with the corresponding compounds of the formula, compounds of the formula I are added in the table.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH244075A CH613691A5 (en) | 1975-02-26 | 1975-02-26 | Process for the preparation of novel 1-indolinylguanidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU655307A3 true SU655307A3 (en) | 1979-03-30 |
Family
ID=4233860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU762324510A SU655307A3 (en) | 1975-02-26 | 1976-02-25 | Method of obtaining guanidine derivatives or salts thereof |
Country Status (23)
| Country | Link |
|---|---|
| JP (1) | JPS51110562A (en) |
| AT (1) | AT358062B (en) |
| AU (1) | AU505134B2 (en) |
| BE (1) | BE838903A (en) |
| CA (1) | CA1071640A (en) |
| CH (1) | CH613691A5 (en) |
| DD (1) | DD123883A5 (en) |
| DE (1) | DE2605981A1 (en) |
| DK (1) | DK62676A (en) |
| ES (1) | ES445477A1 (en) |
| FI (1) | FI760385A7 (en) |
| FR (1) | FR2302090A1 (en) |
| GB (1) | GB1531611A (en) |
| IE (1) | IE42644B1 (en) |
| IL (1) | IL49097A (en) |
| NL (1) | NL7601728A (en) |
| NO (1) | NO760537L (en) |
| NZ (1) | NZ180109A (en) |
| PT (1) | PT64838B (en) |
| SE (1) | SE411119B (en) |
| SU (1) | SU655307A3 (en) |
| YU (1) | YU47076A (en) |
| ZA (1) | ZA761155B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2737064A1 (en) * | 1976-08-27 | 1978-03-09 | Sandoz Ag | INDOLIN-1-YLGUANIDINE DERIVATIVES, THEIR USE AND PRODUCTION |
| JP4943715B2 (en) * | 2006-02-27 | 2012-05-30 | 株式会社タダノ | Counterweight device for mobile crane |
-
1975
- 1975-02-26 CH CH244075A patent/CH613691A5/en not_active IP Right Cessation
-
1976
- 1976-02-14 DE DE19762605981 patent/DE2605981A1/en not_active Ceased
- 1976-02-17 DK DK62676*#A patent/DK62676A/en not_active Application Discontinuation
- 1976-02-17 FI FI760385A patent/FI760385A7/fi not_active Application Discontinuation
- 1976-02-18 NO NO760537A patent/NO760537L/no unknown
- 1976-02-19 SE SE7602000A patent/SE411119B/en unknown
- 1976-02-20 NL NL7601728A patent/NL7601728A/en unknown
- 1976-02-23 GB GB7002/76A patent/GB1531611A/en not_active Expired
- 1976-02-24 NZ NZ180109A patent/NZ180109A/en unknown
- 1976-02-24 DD DD191457A patent/DD123883A5/xx unknown
- 1976-02-24 ES ES445477A patent/ES445477A1/en not_active Expired
- 1976-02-24 BE BE164609A patent/BE838903A/en unknown
- 1976-02-24 PT PT64838A patent/PT64838B/en unknown
- 1976-02-24 CA CA246,492A patent/CA1071640A/en not_active Expired
- 1976-02-24 IL IL49097A patent/IL49097A/en unknown
- 1976-02-24 FR FR7605036A patent/FR2302090A1/en active Granted
- 1976-02-25 AT AT136476A patent/AT358062B/en not_active IP Right Cessation
- 1976-02-25 JP JP51019038A patent/JPS51110562A/ja active Pending
- 1976-02-25 IE IE371/76A patent/IE42644B1/en unknown
- 1976-02-25 YU YU00470/76A patent/YU47076A/en unknown
- 1976-02-25 SU SU762324510A patent/SU655307A3/en active
- 1976-02-26 ZA ZA761155A patent/ZA761155B/en unknown
- 1976-02-26 AU AU11461/76A patent/AU505134B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2302090A1 (en) | 1976-09-24 |
| FR2302090B1 (en) | 1979-09-21 |
| CA1071640A (en) | 1980-02-12 |
| NZ180109A (en) | 1978-06-20 |
| YU47076A (en) | 1982-02-28 |
| AU505134B2 (en) | 1979-11-08 |
| DD123883A5 (en) | 1977-01-19 |
| ZA761155B (en) | 1977-09-28 |
| NL7601728A (en) | 1976-08-30 |
| FI760385A7 (en) | 1976-08-27 |
| IE42644B1 (en) | 1980-09-24 |
| JPS51110562A (en) | 1976-09-30 |
| IL49097A (en) | 1979-01-31 |
| GB1531611A (en) | 1978-11-08 |
| ATA136476A (en) | 1980-01-15 |
| SE411119B (en) | 1979-12-03 |
| AT358062B (en) | 1980-08-25 |
| IL49097A0 (en) | 1976-04-30 |
| ES445477A1 (en) | 1977-10-16 |
| DE2605981A1 (en) | 1976-09-09 |
| IE42644L (en) | 1976-08-26 |
| SE7602000L (en) | 1976-08-27 |
| DK62676A (en) | 1976-08-27 |
| CH613691A5 (en) | 1979-10-15 |
| AU1146176A (en) | 1977-09-01 |
| PT64838B (en) | 1977-09-06 |
| NO760537L (en) | 1976-08-27 |
| PT64838A (en) | 1976-03-01 |
| BE838903A (en) | 1976-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR850000888B1 (en) | Process for preparing trisubstituted imidazole derivatives | |
| SU446966A1 (en) | Method for producing 1,2,3,6-tetrahydro4-pyridylmethylcarboxylic acid ester derivatives | |
| SU537626A3 (en) | Method for producing alkanolamine derivatives | |
| SU481155A3 (en) | Production method - (furyl-methyl) morphinans | |
| SU479290A3 (en) | The method of obtaining 2- (furylmethyl) -6,7 benzomorfan | |
| SK14672001A3 (en) | Novel synthesis and crystallization of piperazine ring-containing compounds | |
| NO139169B (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE AMINOAL ALCOHOL DERIVATIVES OF TRANS-HYDROXY-CINNAMIC ACIDS | |
| SU655307A3 (en) | Method of obtaining guanidine derivatives or salts thereof | |
| US3201406A (en) | Pyridylcoumarins | |
| US3317545A (en) | [2-(2, 6-dimethylpiperidino)ethyl]guanidines and intermediates | |
| US3787423A (en) | Beta-picolyloxy ester of(3-trifluoromethylphenoxy)(4-chlorophenyl)acetic acid and derivatives | |
| SU588917A3 (en) | Method of preparing 1-/2(b-naphthyloxy)-ethyl/-3-methylpyrazolone-5 | |
| SU419031A3 (en) | METHOD FOR PREPARING COMPLEX ETHERS 1,2,3,6-TETRAGIDRO-4-Pyridyl Methyl Carbo Novo and Acids with Their Salts or Quarterly Salts | |
| US3202666A (en) | Substituted 9h-pyrido (3-4-b) indole-1 carboxylic acid and derivatives | |
| US5654429A (en) | Method for the preparation of 3-amino-2-chloro-4-alkylpyridines | |
| US3433802A (en) | 3-(n-lower-alkylanilino)pyrrolidines | |
| SU464116A3 (en) | The method of obtaining the substituted aminoalkyl esters of thiol-carbamic acid | |
| NO133230B (en) | ||
| US5192795A (en) | 2-(aminoalkyl)pyrrolealdehydes, process for their preparation and their use | |
| KR850000427B1 (en) | Method for preparing pyrrole derivative | |
| SU417938A3 (en) | METHOD OF OBTAINING 1- | |
| KR920005828B1 (en) | Process for preparing salt of 2-(2-aminomethyl)-thiomethyl-5-dimethyl amino methylfuran | |
| US2701250A (en) | Process of producing indole-3-acetic acids | |
| SU791232A3 (en) | Method of preparing 2-arylamino-2-imidazoline derivatives | |
| SU618040A3 (en) | Method of obtaining cyanpyridine derivatives or salts thereof |